Tag: covaxin

New Delhi: Phase II trials of the indigenously developed COVID-19 vaccine, Covaxin, is likely to begin on Monday, according to a media report on Sunday. Covaxin has been developed by ...

Bhubaneswar: The preparations for the commencement of the second phase of the human clinical trial of India’s indigenous COVID-19 vaccine ‘Covaxin’ is underway at a hospital here, according to the ...

Bhubaneswar: SUM Hospital is all set to conduct the second phase of the human clinical trial of India's indigenous COVID-19 vaccine Covaxin from next week. The first phase trial was ...

New Delhi: Covaxin, the indigenously developed COVID-19 vaccine, has been found to be safe, according to preliminary results of Phase-I clinical trials. Covaxin is developed by Hyderabad-based Bharat Biotech in ...

Hyderabad: The phase-2 clinical trial of the indigenously developed Covaxin began on Tuesday in Nagpur. Bharat Biotech, the Hyderabad-based firm behind it, is testing the vaccine at Nagpur's Gillurkar Hospital. ...

New Delhi: The first part of the phase-1 trials of India's indigenous COVID-19 vaccine, Covaxin, has produced "encouraging" results, said the principal investigator of the team at Post-Graduate Institute (PGI) ...

Bhubaneswar: A Department of Community Medicine lab was inaugurated at SUM Hospital here on Monday to undertake human clinical trials of the potential coronavirus vaccine ‘Covaxin’, hospital authorities informed. The ...

New Delhi: AIIMS Delhi will start human trials of Covaxin — country’s first indigenous COVID-19 vaccine — next week with 100 healthy volunteers in the age group of 18-55 years. ...

New Delhi: Experts and medicos have criticised the Indian Council of Medical Research’s (ICMR) recent announcement that the indigenous COVID-19 vaccine, COVAXIN, will be available for public use by August ...

Hyderabad: The country's first potential COVID-19 vaccine has received the green light from Drug Controller General of India (DCGI) for Phase I and II human clinical trials. The trials will ...